The agreement not only eliminates existing confusion among potential customers as to patent and licensing obligations, but it also provides a clear demarcation of responsibilities for support of these foaming technologies. Dow will continue to offer resins specially formulated to optimize foaming results while MuCell will provide hands-on technology transfer equipment and technical support to customers.
“Dow has a great business relationship with MuCell and we look forward to creating the new portfolio together,” said Greg Bunker, Associate Marketing Director at Dow. “Foaming films is an excellent route to more sustainable packaging by reducing the usage of resin by 10-20 percent. Through this agreement, both companies are demonstrating their commitment to create superior foamed products that have less impact on the environment. The results will help our customers address their sustainability platforms and develop low environmental impact technology.”
This agreement follows from a similar strategic agreement from earlier this year, wherein Dow and MuCell Extrusion LLC reached an agreement for MuCell Extrusion to exclusively license Dow's patent family on flat sheet resin technology.
“We provide expertise in process development and equipment packages necessary to implement the technology, and Dow offers formulation expertise in resins to streamline the process. This agreement not only marries two steps in the value chain, supply and processing, but that all of the relevant intellectual property for both film and flat sheet resin technology has now been bundled into one source,” said Mark Lindenfelzer, president of MuCell Extrusion LLC. “We have no doubt that this will be a successful venture for MuCell, Dow and our clients.”
For more information about Dow's flexible packaging solutions, please visit Flexible Food and Specialty Packaging. To learn more about MuCell, please visit MuCell Extrusion.